Unresectable Pancreatic Neuroendocrine Tumor
1 clinical trials · Condition
◉ Watch Unresectable Pancreatic Neuroendocrine Tumor
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors (NCT05687123) | National Cancer Institute (NCI) | 2024-08-14 |
Track Unresectable Pancreatic Neuroendocrine Tumor automatically
Every clearance here is in the API, with alerts when new ones post.